Accès ouvert
2026
article
OpenAlex
Pengfei Tian, Zonglin Chen, Xin Yu, Biaojie Fang et autres
Objective Acute severe ulcerative colitis (ASUC) is a life-threatening condition, and biologic-refractory patients may ultimately require surgery. The clinical role of individualised integrative management including traditional Chinese medicine (TCM) in surgery-intended ASUC remains uncertain. Methods This single-centre retrospective exploratory case series included …
cn
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Shilong Jiang, Junyan Liu, Hui Li, Chan Zou et autres
Identifying novel therapeutic targets and drugs is crucial for treating triple-negative breast cancer (TNBC). Bufalin, a key active ingredient of the traditional Chinese medicine HuaChansu, has been employed in tumor therapy. Here, SPR-LC-MS/MS is employed to characterize the targets of Bufalin and …
cn
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Shilong Jiang, Keyi Liu, Ting Jiang, Hui Li et autres
Target identification in natural products plays a critical role in the development of innovative drugs. Bufalin, a compound derived from traditional medicines, has shown promising anti-cancer activity; however, its precise molecular mechanism of action remains unclear. Here, we employ artificial intelligence, molecular …
cn
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Pengfei Tian, Zonglin Chen, Xintian Wang, Xin Feng Yu et autres
cn
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Yi‐Zhi Li, Zonglin Chen, Ziyuan Ding, Dan Mei et autres
Deep learning (DL) models have shown promise in predicting axillary lymph node (ALN) status. However, most existing DL models were classification-only models and did not consider the practical application scenarios of multi-view joint prediction. Here, we propose a Multi-Task Learning (MTL) and …
cn
(code pays fourni par la source)
2025
article
OpenAlex
Xiaoya Wan, Shilong Jiang, Yidi Guan, Yi‐Zhi Li et autres
cn, us
(code pays fourni par la source)
2025
article
OpenAlex
Linhao He, Jiaying He, Ting Jiang, Xiaoya Wan et autres
cn
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Xiaoya Wan, Xiaobao Zhao, Yizhi Li, Tianlong Shan et autres
Eukaryotic elongation factor 2 kinase (eEF2K) has been considered as a putative target for cancer therapy; however, the underlying mechanisms of eEF2K in triple-negative breast cancer (TNBC) progression remain to be fully elucidated. In this study, it is shown that eEF2K is …
cn, us
(code pays fourni par la source)
2024
retraction
OpenAlex
Zonglin Chen, Lei Pei, Danhua Zhang, Feng Xu et autres
cn
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Changxin Zhong, Rongfeng Zhu, Ting Jiang, Sheng Tian et autres
Dysregulated eEF2K expression is implicated in the pathogenesis of many human cancers, including triple-negative breast cancer (TNBC), making it a plausible therapeutic target. However, specific eEF2K inhibitors with potent anti-cancer activity have not been available so far. Targeted protein degradation has emerged …
cn, us
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Ting Jiang, Jiaojiao Zhu, Shilong Jiang, Zonglin Chen et autres
In this study, it is found that the lncRNA, DNA damage inducible transcript 4 antisense RNA1 (DDIT4-AS1), is highly expressed in triple-negative breast cancer (TNBC) cell lines and tissues due to H3K27 acetylation in the promoter region, and promotes the proliferation, migration, …
cn, us
(code pays fourni par la source)
Accès ouvert
2023
supplementary-materials
OpenAlex
Marcus Schmidt, Birte Hellwig, Seddik Hammad, Amnah Othman et autres
PDF file - 722K